Sagar Uttarkar
Research scientist
Cancer Genomics
Oncology Institute of Southern Switzerland
Switzerland
Biography
PhD Researcher at University of Münster,Institute of Biochemistry,Karl-Heinz Klempnauer,Germany. worked as Research Assistant in Advanced Centre for Treatment, Research and Education in Cancer and University of Oxford, Structural Genomics Consortium (SGC).
Research Interest
Molecular Biology, Genetics, Cancer Research, Immunology, Oncology, Clinical Pharmacology ,Clinical Immunology, Hematology, Research experience
Publications
-
Uttarkar S, Piontek T, Dukare S, Schomburg C, Schlenke P, Berdel WE, Muller-Tidow C, Schmidt TJ, Klempnauer KH. Small-molecule disruption of the Myb/p300 cooperation targets acute myeloid leukemia cells. Molecular cancer therapeutics. 2016 Jan 1:molcanther-0185.
-
Uttarkar S, Dukare S, Bopp B, Goblirsch M, Jose J, Klempnauer KH. Naphthol AS-E phosphate inhibits the activity of the transcription factor Myb by blocking the interaction with the KIX domain of the coactivator p300. Molecular cancer therapeutics. 2015 Jun 1;14(6):1276-85.
-
Uttarkar S, Dassé E, Coulibaly A, Steinmann S, Jakobs A, Schomburg C, Trentmann A, Jose J, Schlenke P, Berdel WE, Schmidt TJ. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction. Blood. 2016 Mar 3;127(9):1173-82.
